{"id":5801,"date":"2022-07-11T12:38:46","date_gmt":"2022-07-11T11:38:46","guid":{"rendered":"https:\/\/arrayjet.com\/?post_type=webinars&p=5801"},"modified":"2023-02-20T10:18:10","modified_gmt":"2023-02-20T10:18:10","slug":"seromics-decoding-the-antibody-fingerprint","status":"publish","type":"webinars","link":"https:\/\/arrayjet.com\/webinars\/seromics-decoding-the-antibody-fingerprint","title":{"rendered":"Seromics: Decoding the Antibody Fingerprint"},"content":{"rendered":"\n

For this webinar, our guest speaker was Tyler Hulett, PhD, Head of Biomarker Development at CDI Laboratories<\/a>. CDI is well-known for developing HuProt\u2122 – the largest protein microarray in the world – powered by Arrayjet technology.<\/p>\n\n\n\n

Learning Objectives<\/h2>\n\n\n\n

Each individual carries a ‘fingerprint’ of antibodies that describes a lifetime of immune experiences to foods, allergens, viruses, the microbiome, and other exposures. This fingerprint is exceptionally unique to each individual and can remain stable for decades – but what does it mean?<\/p>\n\n\n\n

This talk discusses the potential importance of anti-viral and autoantibody seromics technologies – what we already know about the antibody fingerprint – and what we still don’t know – using example data from SARS-CoV-2, cancer, and autoimmune patients.<\/p>\n\n\n\n

\n